Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
- PMID: 23402561
- PMCID: PMC3626837
- DOI: 10.1186/1471-2458-13-131
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Abstract
Background: Incidence of acute rheumatic fever (ARF) and prevalence of rheumatic heart disease (RHD) in the Pacific region, including New Caledonia, are amongst the highest in the world. The main priority of long-term management of ARF or RHD is to ensure secondary prophylaxis is adhered to. The objectives of this study were to evaluate rates of adherence in people receiving antibiotic prophylaxis by intramuscular injections of penicillin in Lifou and to determine the factors associated with a poor adherence in this population.
Methods: We conducted a retrospective cohort study and we included 70 patients receiving injections of antibiotic prophylaxis to prevent ARF recurrence on the island of Lifou. Patients were classified as "good-adherent" when the rate of adherence was ≥80% of the expected injections and as "poor-adherent" when it was <80%. Statistical analysis to identify factors associated with adherence was performed using a multivariate logistic regression model.
Results: Our study showed that 46% of patients from Lifou receiving antibiotic prophylaxis for ARF or RHD had a rate of adherence <80% and were therefore at high risk of recurrence of ARF. Three independent factors were protective against poor adherence: a household with more than five people (odds ratio, 0.25; 95% confidence interval [CI], 0.08 to 0.75), a previous medical history of symptomatic ARF (odds ratio, 0.20; 95% CI, 0.04 to 0.98) and an adequate healthcare coverage (odds ratio, 0.21; 95% CI 0.06 to 0.72).
Conclusions: To improve adherence to secondary prophylaxis in Lifou, we therefore propose the following recommendations arising from the results of this study: i) identifying patients receiving antibiotic prophylaxis without medical history of ARF to strengthen their therapeutic education and ii) improving the medical coverage in patients with ARF or RHD. We also recommend that the nurse designated for the ARF prevention program in Lifou coordinate an active recall system based on an updated local register. But the key point to improve adherence among Melanesian patients is probably to give appropriate information regarding the disease and the treatment, taking into account the Melanesian perceptions of the disease.
Figures
Similar articles
-
How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.J Am Heart Assoc. 2018 Dec 18;7(24):e010223. doi: 10.1161/JAHA.118.010223. J Am Heart Assoc. 2018. PMID: 30561268 Free PMC article.
-
Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.Cardiol Rev. 2016 Mar-Apr;24(2):94-8. doi: 10.1097/CRD.0000000000000065. Cardiol Rev. 2016. PMID: 25807106 Review.
-
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.Int J Equity Health. 2017 Nov 17;16(1):201. doi: 10.1186/s12939-017-0700-1. Int J Equity Health. 2017. PMID: 29149897 Free PMC article.
-
Clonidine for pain-related distress in Aboriginal children on a penicillin regimen to prevent recurrence of rheumatic fever.Rural Remote Health. 2020 Nov;20(4):5930. doi: 10.22605/RRH5930. Epub 2020 Nov 5. Rural Remote Health. 2020. PMID: 33147979
-
Adherence to secondary antibiotic prophylaxis among patients with acute rheumatic fever and/or rheumatic heart disease: a systematic review and meta-analysis.BMJ Open. 2024 Nov 14;14(11):e082191. doi: 10.1136/bmjopen-2023-082191. BMJ Open. 2024. PMID: 39542478 Free PMC article.
Cited by
-
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.Nat Rev Cardiol. 2013 May;10(5):284-92. doi: 10.1038/nrcardio.2013.34. Epub 2013 Apr 2. Nat Rev Cardiol. 2013. PMID: 23546444 Review.
-
An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt.Glob Cardiol Sci Pract. 2015 Oct 17;2015(3):40. doi: 10.5339/gcsp.2015.40. eCollection 2015. Glob Cardiol Sci Pract. 2015. PMID: 26779516 Free PMC article.
-
Rheumatic Heart Disease in the Developing World.Struct Heart. 2023 Sep 19;7(6):100219. doi: 10.1016/j.shj.2023.100219. eCollection 2023 Nov. Struct Heart. 2023. PMID: 38046860 Free PMC article. Review.
-
Rheumatic heart disease screening: Current concepts and challenges.Ann Pediatr Cardiol. 2017 Jan-Apr;10(1):39-49. doi: 10.4103/0974-2069.197051. Ann Pediatr Cardiol. 2017. PMID: 28163427 Free PMC article. Review.
-
Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.Indian Heart J. 2021 Mar-Apr;73(2):169-173. doi: 10.1016/j.ihj.2020.11.151. Epub 2020 Dec 7. Indian Heart J. 2021. PMID: 33865513 Free PMC article.
References
-
- WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 October - 1 November, 2001) Geneva Switzerland; 2001. 2004.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources